Growing prevalence of chronic diseases, increasing preference for IV iron over oral therapies, and strong U.S. market leadership drive global expansion at 9.31% CAGR.Austin, United States, March 26, ...

SAN ANTONIO—A study presented at the 2025 annual meeting of the ASA (abstract A3188) has concluded that anemia is a risk factor for cognitive and functional decline after surgery in older adults. The ...

Intravenous ferumoxytol shows higher efficacy than oral iron in the treatment of anemia in pregnant women, improving ...

Objective: We conducted a meta-analysis of randomized clinical trials evaluating the clinical effects of ferric carboxymaltose therapy compared to other intravenous iron in improving hemoglobin and ...

In a phase 3 trial, oral ferric citrate effectively raised hemoglobin and improved iron parameters in Taiwanese patients with iron deficiency anemia over 16 weeks. Ferric citrate significantly ...

Please provide your email address to receive an email when new articles are posted on . IV iron is the most cost-effective option for women with iron deficiency anemia and heavy menstrual bleeding.

IV iron dextran is most cost-effective, yielding 19.26 QALYs compared with 19.10 QALYs for oral ferrous sulfate. (HealthDay News) — Intravenous (IV) iron dextran is the most cost-effective strategy ...

The researchers noted that "altered iron metabolism may represent a potentially modifiable systemic correlate of the AD phenotypes." HealthDay News — Iron deficiency without anemia is a common feature ...

Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a six-fold rise in screening rates for iron deficiency in ...

Within a year of initiation, a multidisciplinary project to improve screening and treatment for iron deficiency in pregnancy resulted in a sixfold rise in screening rates for iron deficiency in ...